Neurotropin


Combined with:

Loxonin
Lyrica
Mucosta

Indications and Reactions:

Role Indications Reactions
Secondary
Pain 12.2%
Product Used For Unknown Indication 9.3%
Sciatica 8.4%
Local Anaesthesia 7.2%
Hypertension 6.0%
Back Pain 5.4%
Rheumatoid Arthritis 5.4%
Lumbar Spinal Stenosis 5.1%
Hypoaesthesia 4.8%
Insomnia 4.5%
Constipation 4.2%
Diabetes Mellitus 4.2%
Drug Use For Unknown Indication 3.9%
Analgesic Therapy 3.6%
Parkinson's Disease 3.6%
Cardiovascular Disorder 3.0%
Herpes Zoster 2.7%
Epidural Anaesthesia 2.4%
Post Herpetic Neuralgia 2.4%
Gastritis Prophylaxis 2.1%
Hepatic Function Abnormal 8.5%
Interstitial Lung Disease 8.5%
Pharyngeal Oedema 8.5%
Respiratory Failure 8.5%
Pain 6.4%
Agranulocytosis 4.3%
Anaphylactic Shock 4.3%
Blood Creatine Phosphokinase Increased 4.3%
Gamma-glutamyltransferase Increased 4.3%
Head Injury 4.3%
Hypothermia 4.3%
Malaise 4.3%
Memory Impairment 4.3%
Multi-organ Failure 4.3%
Respiratory Depression 4.3%
Shock 4.3%
Vomiting 4.3%
White Blood Cell Count Increased 4.3%
Cystitis 2.1%
Drug Eruption 2.1%
Concomitant
Pain 23.6%
Prophylaxis 10.2%
Hypertension 9.9%
Rheumatoid Arthritis 7.8%
Product Used For Unknown Indication 7.7%
Spinal Osteoarthritis 4.3%
Constipation 4.2%
Insomnia 3.7%
Osteoporosis 3.6%
Back Pain 3.2%
Post Herpetic Neuralgia 3.1%
Gastritis 3.0%
Psoriasis 2.4%
Hyperlipidaemia 2.2%
Analgesic Therapy 2.1%
Herpes Zoster 2.0%
Diabetes Mellitus 2.0%
Depression 1.7%
Lumbar Spinal Stenosis 1.7%
Drug Use For Unknown Indication 1.6%
Drug Prescribing Error 8.1%
Rash 7.6%
Interstitial Lung Disease 7.1%
Vomiting 6.6%
Pneumonia 6.1%
Tremor 5.6%
Chest Discomfort 5.1%
Liver Disorder 5.1%
Pyrexia 5.1%
Renal Failure Acute 4.6%
Spinal Compression Fracture 4.6%
White Blood Cell Count Decreased 4.6%
Hepatic Function Abnormal 4.1%
Somnolence 4.1%
Urinary Tract Infection 4.1%
Dizziness 3.6%
Drug Eruption 3.6%
Dyspnoea 3.6%
Nausea 3.6%
Platelet Count Decreased 3.6%

Drug Data